NDC 00363-7174-14 — LEG CRAMPS PM oyster shell calcium carbonate

🆔 Identity & classification

FDA NDC (as labeled) 0363-7174-14

Product NDC 0363-7174

11-digit billing NDC 00363717414

UNII S003A158SB, G0R4UBI2ZZ, C88X29Y479, ETJ7Z6XBU4, 70FD1KFU70, 789U1901C5 +4 more

UPC 0311917135038

SPL Set ID d8c7ec58-5453-0e58-e053-2995a90abff1

Established class (EPC) Copper-containing Intrauterine Device

Physiologic effect Decreased Embryonic Implantation; Decreased Sperm Motility; Inhibit Ovum Fertilization

Chemical class Copper

DEA schedule Non-controlled

Marketing category UNAPPROVED HOMEOPATHIC

Marketing status On market

FDA listing status Listed (active directory)

Marketing start 2023-05-21

Route ORAL

Dosage form TABLET

Substance CINCHONA OFFICINALIS BARK; MATRICARIA RECUTITA; LYCOPODIUM CLAVATUM SPORE; SILICON DIOXIDE; SULFUR; COPPER; CAUSTICUM; TOXICODENDRON PUBESCENS LEAF; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE

Why two NDCs? The FDA registers this code as 0363-7174-14 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00363-7174-14. Same drug, same package — only the format differs.

Where does this data come from?

Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerWalgreen Company

Labeler code00363

First marketedMay 2023

Product typeHuman Otc Drug

Portfolio468 products on file

🔎 All NDCs from Walgreen Company

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).

Where does this data come from?

Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

Leg Cramps PM is a homeopathic tablet taken by mouth that contains multiple ingredients traditionally used in homeopathic practice for nighttime leg discomfort. The formula includes mineral and plant-based substances such as calcium carbonate, magnesium phosphate, copper, sulfur, and extracts from chamomile, cinchona bark, and other botanicals. Homeopathic products are marketed based on traditional homeopathic principles and have not been evaluated by the FDA for effectiveness or safety.

Patient education

📘 MedlinePlus patient leaflet ↗

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →

Where does this data come from?

Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color white

ShapeRound

Size9 mm

ScoringNot scored

One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.

Where does this data come from?

Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

UNII D9C330MD8B
Copovidone is a synthetic polymer made by combining two types of plastic-like molecules. It acts as a binder and film-former to help hold tablet ingredients together and improve how the medicine dissolves in your body.
UNII 2S7830E561
Crospovidone is a synthetic polymer derived from povidone. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the active ingredient can be absorbed.
UNII EWQ57Q8I5X
Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
UNII 3OWL53L36A
A natural sugar alcohol derived from seaweed or synthesized in the lab. It's used as a filler to add bulk, a sweetener in sugar-free formulas, and a disintegrant to help tablets break apart in the stomach.
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
UNII 506T60A25R
Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.

7 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesCopovidone, Crospovidone, Lactose, Magnesium stearate, Mannitol, Microcrystalline cellulose, Silicon dioxide, Sorbitol.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?

Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?

No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.

Why might an inactive ingredient be missing?

Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.

Can inactive ingredients matter?

Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price system	Per each	Per package
Retail pharmacies payNADAC · weekly	Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo	No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly	No Part D plan price is available for this NDC in our data.

ℹ️

No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.

Where does this data come from?

NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

Product	Labeler	Pack	NADAC/unit	TE	Status	Price vs. this
Leg Cramps Pm 3 [hp_X]/1; 6 [hp_X]/1; 12 [hp_X]/1; 12 [hp_X]/1; 6 [hp_X]/1; 12 [hp_X]/1; 12 [hp_X]/1; 6 [hp_X]this 00363-7174-14	Walgreen	50 tablets	—	—	FDA listed	—

About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.

Where does this data come from?

Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️

2023

On the market since

May 2023

📍

2026

Currently FDA-listed

3 years listed

🔒

·

No generic listed yet

brand only

ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?

Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for LEG CRAMPS PM (this brand).

Top reported reactions

Hyponatraemia1

Hypotension1

Loss Of Consciousness1

Mediastinal Mass1

Small Cell Lung Cancer1

Somnolence1

Urinary Retention1

Reporter sex

Male · 67%

Female · 33%

Reports over time (by year) — tap or hover for the count & year

Most recent year is provisional (FAERS lags ~3 months).

Where does this data come from?

Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDC	Description	Marketing start	Status
00363-7174-14 You're viewing this	1 BOTTLE, PLASTIC in 1 CARTON (0363-7174-14) / 50 TABLET in 1 BOTTLE, PLASTIC	2023-05-21	Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

LEG CRAMPS PM oyster shell calcium carbonate, crude, causticum, matricaria recutita, cinchona officinalis bark, copper, lycopodium clavatum spore, magnesium phosphate, dibasic trihydrate, toxicodendron pubescens leaf, silicon dioxide, and sulfur 3 [hp_X]/1; 6 [hp_X]/1; 12 [hp_X]/1; 12 [hp_X]/1; 6 [hp_X]/1; 12 [hp_X]/1; 12 [hp_X]/1; 6 [hp_X]/1 TABLET is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand

NDC identity (package / product / labeler codes)	✓ Available
Labeler	✓ Available
Product & package description	✓ Available
Marketing category & status	✓ Available
Active ingredient / dosage form / route	✓ Available
FDA label (SPL via DailyMed)	✓ Available
Package photos	✓ Available
Inactive ingredients (structured)	✓ Available
NADAC pharmacy acquisition price (CMS)	— Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data	— Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk	— Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD)	— Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.

“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?

An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.

Why is there no price listed?

The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.

Is the NDC printed on the package the same as the 11-digit billing NDC?

Yes, they identify this exact package in different formats. The FDA registers it as 0363-7174-14, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 00363-7174-14, written without dashes as 00363717414. The Identity section at the top of this page lists every form of this code.

What do the three segments of this NDC mean?

In 00363-7174-14, the first segment (00363) is the labeler code FDA assigned to Walgreen Company; the middle segment (7174) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (14) identifies this exact package size and type. Together they name one specific package of one specific product.

Is this package still being marketed?

Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Walgreen Company. Listing status can change — the directory data on this page refreshes weekly.

Who lists this product with the FDA?

Walgreen Company is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.

Do I need a prescription for this product?

This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.

This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.

Where does this data come from?

Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.

🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose

🎯 Indications and Usage 63 words ▾

Uses ■ According to homeopathic indications, these ingredients provide temporary relief of symptoms such as: stiffness, limb, joint, leg pain, cramps in calves, feet and legs with accompanying occasional sleeplessness or disrupted sleep, after serious causes have been ruled out by a physician. * These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.

⏱️ Dosage and Administration 98 words ▾

Directions • Suitable for adults and children ages 12 and over. Children under the age of 12: Consult a physician before use. Dissolve entire tablet under tongue OR chew tablet and swallow. • Do not swallow tablet whole. • Dissolve 1-2 tablets under tongue, every 4 hours or as needed.

If the initial dosage is not providing relief, take 1-2 tablets every 15 minutes, for up to 6 doses. • Take at least 10 minutes before or at least 10 minutes after eating or drinking. • Homeopathic remedies may not be effective for everyone. Individual results may vary.

⚠️ Warnings 86 words ▾

Warnings A PHYSICIAN SHOULD ALWAYS BE CONSULTED TO RULE OUT SERIOUS CAUSES. • This product is intended to complement, not replace, standard medical treatment. • Initial worsening of symptoms may occur. • If pregnant or breast-feeding, ask a health professional before use. Stop use and ask a doctor if: • You experience new or worsening symptoms. • Symptoms last longer than 3 days. • Keep out of reach of children. • In case of overdose, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 103 words ▾

Active ingredients Active ingredients Purpose Calcarea Carbonica 12X HPUS cramps in legs, calves, feet and toes Causticum 12X HPUS occasional sleeplessness Chamomilla 6X HPUS occasional sleeplessness Cinchona Officinalis 3X HPUS pain in limbs and joints; cramping in legs Cuprum Metallicum 12X HPUS cramps of limbs, charley horse cramps Lycopodium 12X HPUS disturbed, restless sleep Magnesia Phosphorica 6X HPUS muscle cramps Rhus Toxicodendron 6X HPUS pain and stiffness Silicea 12X HPUS not being able to sleep again after waking Sulphur 6X HPUS occasional sleeplessness, frequent waking during night “HPUS” indicates that the active ingredients are in the official Homeopathic Pharmacopœia of the United States.

🧪 Inactive Ingredients 13 words ▾

Inactive ingredients Copovidone, Crospovidone, Lactose, Magnesium stearate, Mannitol, Microcrystalline cellulose, Silicon dioxide, Sorbitol.

🎯 Purpose 41 words ▾

According to homeopathic indications, these ingredients provide temporary relief of symptoms such as: stiffness, limb, joint, leg pain, cramps in calves, feet and legs with accompanying occasional sleeplessness or disrupted sleep, after serious causes have been ruled out by a physician.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

🔗 Related NDC lookups

🧪 All Oyster Shell Calcium Carbonate, Crude, Causticum, Matricaria Recutita, Cinchona Officinalis Bark, Copper, Lycopodium Clavatum Spore, Magnesium Phosphate, Dibasic Trihydrate, Toxicodendron Pubescens Leaf, Silicon Dioxide, And Sulfur NDCsSame ingredient 🏭 All Walgreen labeler NDCsLabeler code 00363 📚 All Calculi Dissolution Agent NDCsDrug class